Pappas Capital has more than 85 investments in companies operating within the United States and Canada. They typically invest in companies developing treatments for human diseases. Notable investments made by the firm include: Allievex, Reneo Pharmaceuticals, Ribometrix, Mirum Pharmaceuticals, Milestone Pharmaceuticals, CuraSen Therapeutics, 4D Molecular Therapies, Amplyx Pharmaceuticals, and OrphoMed.
OrphoMed is a clinical-stage biotechnology company with a proprietary dimer therapeutics platform. The company is focused on developing treatments for patients with gastrointestinal disorders.
A biopharmaceutical company focused on identifying cancer therapies
A biopharmaceutical company focused to create products to treat rare and ultra-rare diseases
Amplyx Pharmaceuticals, Inc. is a preclinical stage company focusing on the development of small molecule drugs.
4D Molecular Therapeutics designs, develops and commercializes products for gene therapy.
A drug development company focused on therapeutics for diseases of the nervous system
IlluminOss Medical is a East Providence, Rhode Island-based healthcare company founded by Arnold Peter Weiss.
Mirum Pharmaceuticals is a Menlo Park, California-based company.